Life sciences and healthcare
Hall of Fame
The lawyers at the very top of the profession, widely known and respected by peers and clients for their longstanding involvement in market-leading work.
Leading partners
The strongest partners in their field, leading on market-leading deals and endorsed by peers and clients alike.
Bristows LLP
Liz is a highly experienced and well regarded IP specialist with a focus on counselling clients in the Life Sciences sector on national and international patent strategy and litigation. With over 20 years’ experience, Liz is a sought after adviser for Pharmaceutical, Biotech and Medical Devices companies alike and has represented companies in the Life Sciences industry in patent matters in the English Courts all the way up to the Supreme Court. Her extensive experience of coordinating cross-border litigation within Europe and beyond means that her strategic advice is particularly valued making her a trusted commercial adviser to her many clients. Liz is a qualified solicitor advocate, a qualification she has used successfully to obtain an interim injunction on short notice in the High Court. Liz's background in Natural Sciences provides her with an excellent understanding of the technical and commercial issues facing those operating in the life sciences industry. Liz regularly advises clients on the implications of the proposed Unitary Patent and the Unified Patent Court and played an integral part in representing the alleged infringer in the much publicised Bristows UPC real-time mock action. Liz’s work is regularly published in industry journals and she is also a member of EPLAW, EPLIT, and CIPA, sitting on the CIPA Life Sciences Committee. She is frequently asked to comment and lecture on legal issues affecting the Life Sciences Sector and she is a regular speaker at international conferences on strategic considerations for European and International patent litigation. Liz is a tutor on the Oxford University Diploma in Intellectual Property law and Practice course, teaching patent litigation.
Hall of fameKirkland & Ellis International LLP
Nicola Dagg is a partner in the IP litigation team in the London office of Kirkland & Ellis International LLP. Nicola’s practice spans four areas: (1) strategic life sciences patent and product lifecycle advice; (2) patent litigation; (3) co-ordinating global IP enforcement/defence cases; and (4) standard essential patent (SEP) and FRAND disputes. Nicola has tried over 20 cases.
Nicola has extensive experience in pharmaceutical and biologics patent litigation including blockbuster small molecule litigation against generic companies, biologics and biosimilar litigation, antibodies, immunotherapies, genetics, vaccines, diagnostics and gene therapies. Nicola also acts in market leading SEP essentiality, validity and global FRAND adjudication litigation in the tech sector. Having served as UK and European/global co-ordinating counsel for numerous strategic IP litigation cases and drawing on more than 24 years of legal, IP, life sciences and tech experience she helps clients solve their most pressing global challenges.
Bristows LLP
Alex is passionate about the Life Sciences sector and advises about regulatory issues all day every day. Alex’s advice is informed by a BSc in Human Genetics and in-house experience including as GC of a biopharmaceutical company and brings 25 years’ experience advising clients in the sector. In addition to a wide array of contentious (judicial review) matters, he enjoys working with clients to devise and implement regulatory strategies throughout the product life cycle of pharmaceuticals and medical devices. Alex has advised a number of clients in relation to challenging issues including genomics, cell and gene therapies, 3D printing, healthcare Apps, companion diagnostics, borderline products and combination products. Alex has been involved in the development of a number of regulatory frameworks and guidelines. Legal 500 describes Alex as "a straight-talking, commercially astute technology specialist who is always willing to take a view" and who delivers "out-of-the-box solutions".
Hall of fameLinklaters LLP
Marly specialises in all types of global sourcing, supply chain and technology arrangements. She has particular expertise in complex business carve-outs and works across sectors including healthcare, consumer, financial sponsors, media, telecoms, financial services and data-driven businesses. She is also the global co-head of the firm’s Healthcare and Life Sciences sector.
Marly supports clients throughout the full lifecycle of their most important transformations and projects, from initial structuring and procurement to contentious and non-contentious renegotiations and terminations. Her deals often involve cutting-edge uses of technology, data and supply chain, often within complex regulatory frameworks.
She is also experienced in media and broadcasting transactions and related regulation, having been seconded to both the BBC and Ofcom.
Marly is ranked in MergerLinks’ top 5 leading female M&A lawyers in EMEA specialising in commercial carve-outs, and was voted one of the Hot 100 Lawyers by The Lawyer for her sourcing work.
Hall of fameRPC
Partner specialising in clinical negligence claims, health law advice and representation, and clinical trials. One of the leading medical malpractice lawyers in the UK, Dorothy heads up RPC's Medical/Life Sciences team.
Dorothy acts for a variety of medical malpractice insurers, private hospitals, clinics and other healthcare organisations, and individual healthcare practitioners in the defence of a wide range of claims. She has particular expertise in reproductive healthcare, including infertility and an interest in psychiatric cases and in human rights. Dorothy advises on all aspects of medical law, including regulation and inquests, and has expertise in clinical trials and pharmaceuticals.
Hall of fameStevens & Bolton LLP
Partner, handling Litigation, International Arbitration, adjudication and ADR for clients in a variety of sectors. He handles complex disputes arising out of projects and transactions, often with an international dimension.
Stephenson Harwood
A commercial lawyer with a focus on outsourcing, manufacturing and supply chain issues. Dan has over 25 years' experience in advising on a wide variety of commercial relationships, from day-to-day trading activities to one-off projects and strategic alliances.
Dan's practice is broadly split between services and supply chain issues, including manufacturing, procurement and supply at all stages of production, and outsourcing. His practice is particularly focussed on the manufacturing, life sciences, transport and financial services sectors.
Dan’s practice covers clients in the UK as well as those based throughout Europe, the Middle East and the US. He is also admitted as an Avocat Communautaire at the Paris Bar.
Hall of famePowell Gilbert LLP
Senior Counsel and solicitor advocate specialising in intellectual property litigation and healthcare regulatory advice,. particularly large scale patent actions with an international dimension. Acts for a wide range of biotechnology and pharmaceutical companies in disputed IP matters and has had conduct of major cases such as Edwards Lifesciences v Boston Scientific, Illumina v Premaitha and Warner Lambert v Actavis. Also advises clients in industry sectors ranging from petrochemicals to electronics on disputed patent matters. Notable electronics cases include Nokia v Apple, HTC v Apple and Motorola v Microsoft. Has appeared as a solicitor advocate in the High Court, Court of Appeal, House of Lords and CJEU.
Stephenson Harwood
An intellectual property expert with significant experience of advising on both transactions and disputes. Alexandra believes in providing straightforward and practical advice in context. With degrees in both law and chemistry, many of her clients are in the life sciences sector but she also works with luxury brand clients and clients in other sectors.
Alexandra advises on the complete spectrum of intellectual property issues. Her clients range from life sciences companies, such as BTG plc and Vernalis plc, to luxury brand companies such as Moët Hennessy and Richemont.
Alexandra's transaction experience includes advising clients on licensing, partnering, collaboration and R&D agreements as well as on the IP aspects of mergers, acquisitions, investments (including the taking of security over IP) and commercial contracts such as manufacturing and distribution arrangements.
Her dispute experience includes advising clients in relation to claims regarding IP ownership, infringement and validity and in relation to licensing and other contractual matters. She also advises in relation to anti-counterfeiting strategies and enforcement policies. She has experience of both civil and criminal IP litigation.
Alexandra has been named in The Lawyer's Hot 100 – Dealmaker list 2019 which acknowledges her as "representative of emerging talent in the venerable City player". Described as "bright, charming, witty and solution-driven" by Chambers and Partners, she has also been described as "extremely knowledgeable and an excellent communicator who has a unique ability to demystify complex areas of law. She juggles legal business risk with opportunity and then provides robust but pragmatic advice. On top of that, she’s a huge pleasure to work with" (IAM Patent 1000, 2018). According to WTR 1000, 2019 “her enthusiasm is infectious and she has a rare ability to explain difficult issues plainly and simply for the benefit of clients and to their great advantage”. Alexandra is highly recommended for patent transactions (IAM Patent 1000), for trade mark transactions, enforcement and litigation (WTR 100 2019) and for commercial agreements and litigation concerning copyright, trade marks and life sciences patents (Chambers and Partners). She has also been awarded the Lexology Client Choice Award for healthcare and life sciences UK 2018.
Pinsent Masons LLP
Pinsent Masons LLP
Next Generation Partners
Junior partners with significant recognition from clients and peers in the market and key roles on multiple matters.
Bristows LLP
Robert specialises in patent litigation. He has a PhD in molecular genetics and is particularly active for clients within the life sciences sector. Many of the patent and SPC cases Robert has managed in recent years have required the coordination of parallel proceedings in the UK, EPO and other jurisdictions within Europe and elsewhere in the world. He therefore has in-depth knowledge of European litigation and, alongside appearing for clients in the High Court and Court of Appeal, has attended preliminary injunction and main action proceedings in multiple countries within Europe and overseen inspections of pharmaceutical manufacturing processes in India and Japan. Alongside the assessment of validity and infringement issues, his recent cases have included a damages enquiry, a reference to the Court of Justice of the European Union and the availability of Arrow declaratory relief. Robert regularly advises clients on the Unitary Patent and the Unified Patent Court and, in more recent times, on the impact of Brexit. He also advises on other IP rights and is one of a small number of lawyers who have acted in matters concerning plant variety rights. In addition to his litigation experience, Robert assists clients with freedom to operate opinions and due diligence on the intellectual property aspects of commercial transactions. Robert is one of the founding editors of Bristows’ Biotech Review publication.
Hogan Lovells International LLP
Matthew is a disputes Partner in the Global Product Law practice and is co-chair of our London life sciences team. Whether advising a life science company facing a group action in England, or helping a global product manufacturer work through claims across Europe, Matthew's extensive experience of complex, cross-border litigation means he gets the commercial context and quickly finds the best solution.
Slaughter and May
Partner; Claire has a broad corporate and corporate finance practice, advising on all forms of domestic and international M&A transactions, including public takeovers, private acquisitions and disposals, joint ventures, and equity financings. She has particular expertise in the pharmaceutical, life sciences and healthcare and insurance sectors.
Claire also has experience in shareholder activism and has advised a number of corporate clients on recent activist campaigns.
Kirkland & Ellis International LLP
Jin Ooi is an intellectual property litigator in the London office of Kirkland & Ellis International LLP. He is experienced in patent litigation and counselling (including on complex damages inquiries) mainly in the pharmaceutical and life sciences field (second medical use, biosimilars, small molecules, DNA sequencing, vaccines, transgenic animal platforms for antibody discovery), and in the consumer products sector (shaving razors, potentially reduced-risk products including tobacco heating and vapour products, dishwashing tablets, coffee pods and capsules).
He is also experienced in litigating and arbitrating trade secrets disputes in the medical devices (bone cements), tech (LNG carriers) and aviation sector (airplane components, airport businesses), in addition to handling antitrust claims (cathode ray tubes, lithium ion batteries, forklift gas).
Bristows LLP
Claire specialises in commercial and intellectual property transactions, most notably in the life sciences, technology, media and consumer product sectors.Claire advises on a wide variety of commercial and IP transactions (the large majority of which are cross-border) and on corporate and investment deals where IP is an important asset. Before becoming a lawyer, Claire spent a number of years working for Abbott Laboratories' medical device business. Since being at Bristows, Claire has also spent time seconded to the in-house legal team of a leading global pharmaceutical company. She is also a member of the UK Bio Industry Association’s Intellectual Property Advisory Committee.Examples of her recent experience include advising: pharmaceutical, biotech, medical device and digital health companies on joint ventures, R&D collaborations, strategic partnerships and licensing deals (with commercial and academic partners) to bring novel treatments and devices to market leading pharmaceutical companies on acquisitions and disposals of rights in medicinal products and the sale of manufacturing and packaging facilities multinational companies on key COVID-19 projects, including collaborations relating to a multijurisdictional clinical trial for a COVID-19 vaccine, and setting up and operating a COVID-19 testing facility SMEs and international organisations on development, services, manufacturing, supply and distribution agreements for a wide range of pharmaceutical, industrial and consumer products a fast-growing start-up on the IP and commercial arrangements relating to the creation, protection and exploitation of a new children’s character.
Covington & Burling LLP
Simmons & Simmons
Pinsent Masons LLP
Leading associates
Rising stars with regular involvement in their team's key work, and recognition from peers or clients as being ones to watch.
McDermott Will & Emery UK LLP
David is an associate, he focuses his practice on commercial health care, with a background in providing commercial, corporate and financial advice to health care clients. His areas of specialty include procurement, outsourcing and “insourcing” of clinical and non-clinical health care services, private patient services, health care regulatory, advice on medical device regulations as well as leading specialist projects, such as the NHS Proton Beam project.
Visit our website for more: https://www.mwe.com/people/gibson-david/
Baker McKenzie
Comparative Guides
View
Comparative Guides
United Kingdom: Pharmaceutical Advertising
London
Contribution fromBird & Bird LLPBird & Bird LLP